Faron Pharmaceuticals Oy (“Faron” or “the Company”) Faron Announces New Biomarker Data from Phase I/II BEXMAB Study at EHA2023 Hybrid Congress Bexmarilimab mode of action in AML/MDS supported with durable Clever-1 target engagement in bone marrow, with increases observed in T and NK cells…

FORNEBU, Norway, June 9, 2023 /PRNewswire/ — Aker BP (OSE: AKRBP) (OTCQX: AKRBF) has successfully completed the drilling of the Øst Frigg Beta/Epsilon exploration well in the Yggdrasil area. This marks the longest exploration well ever drilled on the Norwegian Continental Shelf and has…

NEW YORK, June 9, 2023 /PRNewswire/ — The global medical billing outsourcing market size is estimated to increase by USD 11,704.49 million from 2022 to 2027. The market’s growth momentum will be progressing at a CAGR of 15.73%. Discover some insights on market size, historic period (2017…

QINGDAO, China, June 9, 2023 /PRNewswire/ — Hisense, the leading consumer electronics and home appliances company, is delighted to announce its official partnership with the Nations League Finals 2023. The sponsorship will be the third time Hisense has been a partner of the finals and…

AMSTERDAM, June 9, 2023 /PRNewswire/ — The Turkish Payment and Electronic Money Institutions Association (TÖDEB) with its 8 members established the first-ever Turkish pavilion at Money 20/20, Amsterdam; one of the most prestigious fairs in the fintech world. At Money 20/20 – Amsterdam,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.